Results 191 to 200 of about 67,015 (304)

Efficacy and Safety of aficamten in Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4.

open access: yesJournal of Cardiac Failure
A. Masri   +25 more
semanticscholar   +1 more source

Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy.

open access: yesJournal of the American College of Cardiology, 2021
Sheila M. Hegde   +15 more
semanticscholar   +1 more source

Low-Dose Mavacamten Initiation in Obstructive Hypertrophic Cardiomyopathy: A Real-World Study in China. [PDF]

open access: yesCardiovasc Ther
Yang W   +8 more
europepmc   +1 more source

Ventricular Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy (Analysis Spanning 60 Years Of Practice): AJC Expert Panel.

open access: yesAmerican Journal of Cardiology, 2022
B. Maron   +23 more
semanticscholar   +1 more source

Hypertension in Patients With Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten. [PDF]

open access: yesJACC Heart Fail
Reza N   +9 more
europepmc   +1 more source

Effect of Aficamten on Cardiac Structure and Function in Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM CMR Substudy.

open access: yesJournal of the American College of Cardiology
A. Masri   +21 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy